Close Menu

NEW YORK– Waters on Tuesday reported that its fourth quarter revenues were flat compared to the year-ago period, while full-year revenues declined 1 percent.

For the three months ended Dec. 31, 2019, Waters' total revenues were $716.3 million, up less than 1 percent from $715.0 million in Q4 2018, and above the consensus Wall Street estimate of $714.9 million.

The effect of foreign currency translation decreased Q4 revenues by 1 percent, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.

Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.